329 related articles for article (PubMed ID: 26292038)
1. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Costello BA; Thompson RH; Stewart-Merrill SB; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK
J Urol; 2016 Feb; 195(2):270-6. PubMed ID: 26292038
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Sharma P; Zargar-Shoshtari K; Caracciolo JT; Fishman M; Poch MA; Pow-Sang J; Sexton WJ; Spiess PE
Urol Oncol; 2015 Aug; 33(8):339.e17-23. PubMed ID: 26094169
[TBL] [Abstract][Full Text] [Related]
3. Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.
Lee J; Suh J; Song C; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H
Ann Surg Oncol; 2022 Apr; 29(4):2473-2479. PubMed ID: 34625877
[TBL] [Abstract][Full Text] [Related]
4. Does Sarcopenia Impact Complications and Overall Survival in Patients Undergoing Radical Nephrectomy for Stage III and IV Kidney Cancer?
Peyton CC; Heavner MG; Rague JT; Krane LS; Hemal AK
J Endourol; 2016 Feb; 30(2):229-36. PubMed ID: 26418428
[TBL] [Abstract][Full Text] [Related]
5. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
[TBL] [Abstract][Full Text] [Related]
6. Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.
Larcher A; Capitanio U; Terrone C; Volpe A; De Angelis P; Dehó F; Fossati N; Dell'Oglio P; Antonelli A; Furlan M; Simeone C; Serni S; Carini M; Minervini A; Fiori C; Porpiglia F; Briganti A; Montorsi F; Bertini R
J Urol; 2016 Oct; 196(4):1008-13. PubMed ID: 27235789
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma.
Psutka SP; Stewart SB; Boorjian SA; Lohse CM; Tollefson MK; Cheville JC; Leibovich BC; Thompson RH
J Urol; 2014 Dec; 192(6):1620-7. PubMed ID: 24931804
[TBL] [Abstract][Full Text] [Related]
8. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
9. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
10. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
11. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Boorjian SA; Lohse CM; Leibovich BC; Tollefson MK
Urol Oncol; 2014 Nov; 32(8):1277-84. PubMed ID: 25017696
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality.
Psutka SP; Carrasco A; Schmit GD; Moynagh MR; Boorjian SA; Frank I; Stewart SB; Thapa P; Tarrell RF; Cheville JC; Tollefson MK
Cancer; 2014 Sep; 120(18):2910-8. PubMed ID: 24840856
[TBL] [Abstract][Full Text] [Related]
13. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
14. Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.
Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Frank I; Carrasco A; Stewart SB; Tarrell R; Thapa P; Tollefson MK
J Urol; 2015 May; 193(5):1507-13. PubMed ID: 25464002
[TBL] [Abstract][Full Text] [Related]
15. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
Lane BR; Campbell SC; Gill IS
J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
[TBL] [Abstract][Full Text] [Related]
16. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
[TBL] [Abstract][Full Text] [Related]
17. Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy.
Yang DY; Thompson RH; Zaid HB; Lohse CM; Rule AD; Boorjian SA; Leibovich BC; Cheville JC; Tollefson MK
J Urol; 2017 Oct; 198(4):795-802. PubMed ID: 28396181
[TBL] [Abstract][Full Text] [Related]
18. Oncological and functional outcomes after radical nephrectomy for renal cell carcinoma: a comprehensive analysis of prognostic factors.
Sejima T; Iwamoto H; Masago T; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
Int J Urol; 2013 Apr; 20(4):382-9. PubMed ID: 23003206
[TBL] [Abstract][Full Text] [Related]
19. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
[TBL] [Abstract][Full Text] [Related]
20. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
